Evidence map›Paper›PMID 26556311›Full record

ArticleThe international journal of biochemistry & cell biology2016

Phenylephrine preconditioning in embryonic heart H9c2 cells is mediated by up-regulation of SUR2B/Kir6.2: A first evidence for functional role of SUR2B in sarcolemmal KATP channels and cardioprotection.

Sofija Jovanović, Thomas Ballantyne, Qingyou Du, Miloš Blagojević, Aleksandar Jovanović

Open access · hybridAbstract read
In one paragraph

Article in The international journal of biochemistry & cell biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Functional Regulation of KFrontiers in pharmacology · 2022
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Sofija JovanovićMedical Research Institute, Division of Cardiovascular & Diabetic Medicine, Ninewells Hospital & Medical School, University of Dundee, UK.
Thomas BallantyneMedical Research Institute, Division of Cardiovascular & Diabetic Medicine, Ninewells Hospital & Medical School, University of Dundee, UK.
Qingyou DuMedical Research Institute, Division of Cardiovascular & Diabetic Medicine, Ninewells Hospital & Medical School, University of Dundee, UK.
Miloš BlagojevićDepartment of Anatomy, Faculty of Veterinary Medicine, University of Belgrade, Belgrade, Serbia.
Aleksandar JovanovićMedical Research Institute, Division of Cardiovascular & Diabetic Medicine, Ninewells Hospital & Medical School, University of Dundee, UK. Electronic address: a.jovanovic@dundee.ac.uk.
Ninewells Hospital · GBUniversity of Belgrade · RSUniversity of Dundee · GB

Funding

British Heart Foundation PG/11/106/29235British Heart Foundation PG/15/28/31384
6 · The paper itself

Abstract

ATP-sensitive K(+) (KATP) channels were originally described in cardiomyocytes, where physiological levels of intracellular ATP keep them in a closed state. Structurally, these channels are composed of pore-forming inward rectifier, Kir6.1 or Kir6.2, and a regulatory, ATP-binding subunit, SUR1, SUR2A or SUR2B. SUR1 and Kir6.2 form pancreatic type of KATP channels, SUR2A and Kir6.2 form cardiac type of KATP channels, SUR2B and Kir6.1 form vascular smooth muscle type of KATP channels. The presence of SUR2B has been described in cardiomyocytes, but its functional significance and role has remained unknown. Pretreatment with phenylephrine (100nM) for 24h increased mRNA levels of SUR2B and Kir6.2, without affecting those levels of SUR1, SUR2A and Kir6.1 in embryonic heart H9c2 cells. Such increase was associated with increased K(+) current through KATP channels and Kir6.2/SUR2B protein complexes as revealed by whole cell patch clamp electrophysiology and immunoprecipitation/Western blotting respectively. Pretreatment with phenylephrine (100nM) generated a cellular phenotype that acquired resistance to chemical hypoxia induced by 2,4-dinitrophenol (DNP; 10mM), which was accompanied by increased in K(+) current in response to DNP (10mM). Cytoprotection afforded by phenylephrine (100nM) was abolished by infection of H9c2 cells with adenovirus containing Kir6.2AFA, a mutant form of Kir6.2 with largely reduced K(+) conductance. Taking all together, the present findings demonstrate that the activation of α1-adrenoceptors up-regulates SUR2B/Kir6.2 to confer cardioprotection. This is the first account of possible physiological role of SUR2B in cardiomyocytes.

Indexed as

2,4-DinitrophenolAdenosine TriphosphateAdrenergic alpha-1 Receptor AgonistsAnimalsCardiotonic AgentsCell HypoxiaCell LineEmbryo, MammalianGene Expression RegulationKATP ChannelsKcnj11 ChannelMutationMyocytes, CardiacPatch-Clamp TechniquesPhenylephrinePotassium Channels, Inwardly Rectifying2,4-DinitrophenolAbcc8 protein, ratAdenosine TriphosphateAdrenergic alpha-1 Receptor AgonistsCardiotonic AgentsKATP ChannelsKcnj11 ChannelPhenylephrinePotassium Channels, Inwardly RectifyingProtein IsoformsProtein SubunitsRNA, MessengerSulfonylurea ReceptorsuK-ATP-1 potassium channelCardiomyocytesCardioprotectionH9c2 cellsPreconditioningSUR2B

Identifiers

PMID26556311
PMCPMC4711337
OpenAlexW2117213480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.